סיטאגליפטין טבע 100 מג
teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 100 mg - sitagliptin
סיטאגליפטין טבע 25 מג
teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 25 mg - sitagliptin
סיטאגליפטין טבע 50 מג
teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 50 mg - sitagliptin
ג'נוביה 25 מג
merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - טבליות מצופות פילם - sitagliptin as monohydrate phosphate 25 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.
ג'נוביה 50 מג
merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - טבליות מצופות פילם - sitagliptin as monohydrate phosphate 50 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.
ג'נוביה 100 מג
merck sharp & dohme (israel - 1996) company ltd, israel - sitagliptin as monohydrate phosphate - טבליות מצופות פילם - sitagliptin as monohydrate phosphate 100 mg - sitagliptin - sitagliptin - januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus.important limitations of use:januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings.januvia has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia.
סיטאפורמין טבע 50 מג1000 מג
teva israel ltd - metformin hydrochloride; sitagliptin as malate - טבליות מצופות פילם - metformin hydrochloride 1000 mg; sitagliptin as malate 50 mg - metformin and sitagliptin
סיטאפורמין טבע 50 מג500 מג
teva israel ltd - metformin hydrochloride; sitagliptin as malate - טבליות מצופות פילם - metformin hydrochloride 500 mg; sitagliptin as malate 50 mg - metformin and sitagliptin
סיטאפורמין טבע 50 מג850 מג
teva israel ltd - metformin hydrochloride; sitagliptin as malate - טבליות מצופות פילם - metformin hydrochloride 850 mg; sitagliptin as malate 50 mg - metformin and sitagliptin
סיטגליפטין אס.קיי. 100 מג
k.s.kim international (sk- pharma) ltd., israel - sitagliptin as hydrochloride monohydrate - טבליות מצופות פילם - sitagliptin as hydrochloride monohydrate 100 mg - sitagliptin